Brooks Laboratories Limited (NSE:BROOKS)
148.99
+8.34 (5.93%)
Apr 25, 2025, 9:24 AM IST
Brooks Laboratories Revenue
Brooks Laboratories had revenue of 384.48M INR in the quarter ending December 31, 2024, with 76.80% growth. This brings the company's revenue in the last twelve months to 769.62M, up 3.36% year-over-year. In the fiscal year ending March 31, 2024, Brooks Laboratories had annual revenue of 794.86M with 25.76% growth.
Revenue (ttm)
769.62M
Revenue Growth
+3.36%
P/S Ratio
5.70
Revenue / Employee
2.63M
Employees
293
Market Cap
4.38B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 794.86M | 162.82M | 25.76% |
Mar 31, 2023 | 632.05M | -279.80M | -30.69% |
Mar 31, 2022 | 911.85M | 139.38M | 18.04% |
Mar 31, 2021 | 772.47M | 75.58M | 10.85% |
Mar 31, 2020 | 696.89M | 146.58M | 26.64% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 516.03B |
Divi's Laboratories | 90.78B |
Cipla | 267.20B |
Mankind Pharma | 116.41B |
Apollo Hospitals Enterprise | 211.46B |
Zydus Lifesciences | 222.47B |
Aurobindo Pharma | 309.22B |
Alkem Laboratories | 127.57B |